Concurrent application of bisphosphonates and external beam radiotherapy in patients with metastatic bone disease from renal cancer

BJU International

Volumn 104, Issue 3, 2009, Pages 417-418

  Vassiliou, Vassilios ^a   Leotsinides, Michael ^a   Kalogeropoulou, Christina ^a   Kardamakis, Dimitrios ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; NARCOTIC ANALGESIC AGENT; ZOLEDRONIC ACID;

BONE DENSITY; BONE METASTASIS; BONE PAIN; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; KIDNEY CANCER; LETTER; PRIORITY JOURNAL; TREATMENT RESPONSE;

BONE DENSITY CONSERVATION AGENTS; BONE NEOPLASMS; CARCINOMA, RENAL CELL; COMBINED MODALITY THERAPY; DIPHOSPHONATES; HUMANS; KIDNEY NEOPLASMS; TREATMENT OUTCOME;

EID: 68049120594     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08767_3.x     Document Type: Letter

References (9)

1. Kijima T, Fujii Y, Suyama T et al. Radiotherapy to bone metastases from renal cell carcinoma with or without zoledronate. BJU Int 2009 : 103 : 620 4
2. Vassiliou V, Kalogeropoulou C, Christopoulos C, Solomou EK, Leotsinides M, Kardamakis D. Combination ibandronate and radiotherapy for the treatment of bone metastases: clinical evaluation and radiologic assessment. Int J Radiat Oncol Biol Phys 2007 : 67 : 264 72
3. Vassiliou V, Kalogeropoulou C, Giannopoulou E, Leotsinides M, Tsota I, Kardamakis D. A novel study investigating the therapeutic outcome of patients with lytic, mixed and sclerotic bone metastases treated with combined radiotherapy and ibandronate. Clin Exp Metastasis 2007 : 24 : 169 78
4. Vassiliou V, Kardamakis D. The management of metastatic bone disease with the combination of bisphosphonates and radiotherapy: From theory to clinical practice. Anticancer Agents Med Chem 2009 : 9 : 326 35
5. Arrington SA, Damron TA, Mann KA, Allen MJ. Concurrent administration of zoledronic acid and irradiation leads to improved bone density, biomechanical strength, and microarchitecture in a mouse model of tumor induced osteolysis. J Surg Oncol 2008 : 97 : 284 90
6. Kouloulias V, Matsopoulos G, Kouvaris J et al. Radiotherapy in conjunction with intravenous infusion of 180mg of disodium pamidronate in management of osteolytic metastases from breast cancer: clinical evaluation, biochemical markers, quality of life, and monitoring of recalcification using assessment of grey-level histogram in plain radiographs. Int J Radiat Oncol Biol Phys 2003 : 57 : 143 57
7. Vassiliou V, Kalogeropoulou C, Petsas T, Leotsinidis M, Kardamakis D. Clinical and radiological evaluation of patients with lytic, mixed and sclerotic bone metastases from solid tumors: Is there a correlation between the clinical status of patients and the type of bone metastases? Clin Exp Metastasis 2007 : 24 : 49 56
8. Zerki J, Ahmed N, Coleman RE, Hancock BW. The skeletal metastatic complications of renal cell carcinoma. Int J Oncol 2001 : 19 : 379 82
9. Toyoda Y, Shinohara N, Harabayashi T et al. Survival and prognostic classification of patients with metastatic renal cell carcinoma of bone. Eur Urol 2007 52 : 163 8